Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient
- 1 August 1982
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 31 (9), 899-907
- https://doi.org/10.1016/0024-3205(82)90547-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogsEuropean Journal of Pharmacology, 1981
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blockerAmerican Heart Journal, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applicationsAmerican Heart Journal, 1979
- Adrenoceptor Blocking DrugsDrugs, 1979
- Beta-adrenergic blockade in acute myocardial infarctionLife Sciences, 1978
- Present state of alpha and beta adrenergic drugs III. Beta blocking agentsAmerican Heart Journal, 1977
- The effect of γ-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular diseasePostgraduate Medical Journal, 1976
- Clinical pharmacology of propranolol.Circulation, 1975
- Perspectives in adrenergic beta‐receptor blockadeClinical Pharmacology & Therapeutics, 1969
- THE PHARMACOLOGICAL DIFFERENTIATION OF ADRENERGIC RECEPTORS*Annals of the New York Academy of Sciences, 1967